Chlorthalidone Tablets, 25 mg recall — Inventia Healthcare Ltd (Class II)
Inventia Healthcare Ltd is recorded by the U.S. Food and Drug Administration (FDA) as recalling Chlorthalidone Tablets, 25 mg — a Class II recall, initiated 2026-06-05 and posted to the FDA enforcement report on 2026-06-24, under recall number D-0610-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Failed Dissolution Specifications”. From the product description, the form is tablets, the strength given is 25 mg and it is marked Rx only. Distribution is recorded as “U.S. Nationwide” — Nationwide (US), with the recalling firm on record in India. It is the only recall number the FDA has filed under event ID 99136. 19 days separate the firm's initiation date from the FDA's report date on this record. It names Inventia Healthcare Limited, Additional Ambernath as the manufacturer. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.
Regulatory snapshot
| Recall number | D-0610-2026 |
|---|---|
| FDA event ID | 99136 |
| Classification | Class II (intermediate regulatory tier) |
| Status | Ongoing |
| Recalling firm | Inventia Healthcare Ltd |
| Recall initiated | 2026-06-05 |
| Reported by FDA | 2026-06-24 |
| Report lag | 19 days from initiation to report |
| Distribution | U.S. Nationwide. — Nationwide (US) |
| Firm location on record | India |
| Product description (source) | Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10 |
Reason reported by FDA
Failed Dissolution Specifications
3 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.
Product identifiers in this record
5 identifying values matched by exact pattern in the 44-word product description above; each is a literal substring of it.
| Product named | Chlorthalidone Tablets |
|---|---|
| Form | Tablets |
| Strength | 25 mg |
| Marketing category | Rx only |
| Manufactured by | Inventia Healthcare Limited, Additional Ambernath |
| Distributed by | Risiong Pharma Holdings, Inc. |
Other Class II recalls with India on record
27 indexed records carry India as the recalling firm's country, against a dataset that is predominantly United States. These are the ones that also share this recall's FDA tier.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| Methohexital Sodium for Injection, 500 mg | D-0662-2026 | Onesource Specialty Pharma Ltd | 500 mg · for Injection | 2026-07-15 |
| Pemetrexed for Injection 100mg/Vial | D-0671-2026 | Reliance Life Sciences Private Ltd | 100mg/Vial · for Injection | 2026-07-15 |
| Pemetrexed for Injection 500mg/Vial | D-0672-2026 | Reliance Life Sciences Private Ltd | 500mg/Vial · for Injection | 2026-07-15 |
| Bortezomib for Injection 3.5mg/Vial | D-0673-2026 | Reliance Life Sciences Private Ltd | 3.5mg/Vial · for Injection | 2026-07-15 |
| Azacitidine for Injection 100mg/Vial | D-0674-2026 | Reliance Life Sciences Private Ltd | 100mg/Vial · for Injection | 2026-07-15 |
| Clomiphene Citrate USP Active Pharmaceutical Ingredient (CAS : 50-41-9), 1 KG | D-0691-2026 | Shimoga Chemicals | 1 KG | 2026-07-15 |
Reported in the same month (2026-06)
74 enforcement reports carry a report date in 2026-06; these 8 are the Class II ones nearest this record.
| Recall record | Recall number | Recalling firm | FDA tier | Reported |
|---|---|---|---|---|
| Alyacen 7/7/7, 0.5mg/0.035mg | D-0588-2026 | Glenmark Pharmaceuticals Inc., Usa | Class II | 2026-06-24 |
| VistaPharm, 25 Grams | D-0589-2026 | Pai Holdings LLC | Class II | 2026-06-24 |
| VistaPharm, 50 Grams | D-0590-2026 | Pai Holdings LLC | Class II | 2026-06-24 |
| VistaPharm, 25 Grams | D-0591-2026 | Pai Holdings LLC | Class II | 2026-06-24 |
| VistaPharm, 50 Grams | D-0592-2026 | Pai Holdings LLC | Class II | 2026-06-24 |
| Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride | D-0593-2026 | Integradose Compounding Services LLC | Class II | 2026-06-24 |
| Aripiprazole Tablets USP, 30 mg | D-0594-2026 | Ajanta Pharma Usa Inc | Class II | 2026-06-24 |
| Buprenorphine HCl, 0.3 mg/mL | D-0596-2026 | Par Health Usa, LLC | Class II | 2026-06-24 |
Nearest Class II recalls by date
213 of 250 indexed records share the Class II tier; the 2 nearest to 2026-06-24 by report date are listed here.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| Pearson Quality Topical Anesthetic Gel (20% Benzocaine) | D-0600-2026 | Keystone Industries | 20% · Gel | 2026-06-24 |
| Quala Dental Products, 20 % | D-0601-2026 | Keystone Industries | 20 % · Gel | 2026-06-24 |
Reading this record
Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual.
Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Inventia Healthcare Ltd (1 indexed records) aggregates this firm across datasets.
Coverage and limits of this record
This page reflects the openFDA enforcement report for D-0610-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.
Source & provenance
- Official source
- https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0610-2026%22
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- 2026-06-24
- Ingested
- 2026-08-22
- Record hash
19b857b9138a2b56
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.